Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Not on Concomitant Methotrexate. Genovese, M. C., Greenwald, M., Codding, C., Cardiel, M. H., Zubrzycka-Sienkiewicz, A., Kivitz, A. J., Wisseh, S., Shay, K., Garg, J. P. WILEY-BLACKWELL. 2014: S1234–S1235
View details for Web of Science ID 000344384906061